1. Home
  2. ILMN vs ASX Comparison

ILMN vs ASX Comparison

Compare ILMN & ASX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • ASX
  • Stock Information
  • Founded
  • ILMN 1998
  • ASX 1984
  • Country
  • ILMN United States
  • ASX Taiwan
  • Employees
  • ILMN N/A
  • ASX N/A
  • Industry
  • ILMN Medical Specialities
  • ASX Semiconductors
  • Sector
  • ILMN Health Care
  • ASX Technology
  • Exchange
  • ILMN Nasdaq
  • ASX Nasdaq
  • Market Cap
  • ILMN 23.6B
  • ASX 22.5B
  • IPO Year
  • ILMN 2000
  • ASX 1995
  • Fundamental
  • Price
  • ILMN $134.95
  • ASX $10.46
  • Analyst Decision
  • ILMN Buy
  • ASX Strong Buy
  • Analyst Count
  • ILMN 17
  • ASX 1
  • Target Price
  • ILMN $163.12
  • ASX N/A
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • ASX 8.0M
  • Earning Date
  • ILMN 02-06-2025
  • ASX 01-30-2025
  • Dividend Yield
  • ILMN N/A
  • ASX 3.05%
  • EPS Growth
  • ILMN N/A
  • ASX N/A
  • EPS
  • ILMN N/A
  • ASX 0.23
  • Revenue
  • ILMN $4,390,000,000.00
  • ASX $18,693,593,707.00
  • Revenue This Year
  • ILMN N/A
  • ASX $6.13
  • Revenue Next Year
  • ILMN $4.05
  • ASX $14.78
  • P/E Ratio
  • ILMN N/A
  • ASX $21.46
  • Revenue Growth
  • ILMN N/A
  • ASX N/A
  • 52 Week Low
  • ILMN $97.36
  • ASX $8.10
  • 52 Week High
  • ILMN $156.66
  • ASX $12.86
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 40.07
  • ASX 59.25
  • Support Level
  • ILMN $130.31
  • ASX $9.81
  • Resistance Level
  • ILMN $137.69
  • ASX $10.55
  • Average True Range (ATR)
  • ILMN 5.08
  • ASX 0.24
  • MACD
  • ILMN -1.03
  • ASX 0.05
  • Stochastic Oscillator
  • ILMN 21.62
  • ASX 87.66

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About ASX ASE Technology Holding Co. Ltd. (each representing Two)

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, Electronic Manufacturing Services contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

Share on Social Networks: